DISCOUNT ZERTIFIKAT - CELSIUS HLDGS Stock

Certificat

DE000ME84EE0

Real-time Bid/Ask 05:14:56 2024-06-27 EDT
41.17 EUR / 42.02 EUR +1.01% Intraday chart for DISCOUNT ZERTIFIKAT - CELSIUS HLDGS
Current month-8.31%
1 month-10.32%
Date Price Change
24-06-27 41.23 +0.12%
24-06-26 41.18 -0.24%
24-06-25 41.28 -3.17%
24-06-24 42.63 -0.05%
24-06-21 42.65 +0.68%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 04:16 am

More quotes

Static data

Product typeDiscount-Zertifikate
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME84EE
ISINDE000ME84EE0
Date issued 2024-02-02
Maturity 2024-12-20 (177 Days)
Parity 1 : 1
Emission price 37.32
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 45.94
Lowest since issue 36.74
Spread 0.69
Spread %1.64%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
56.56 USD
Average target price
83.43 USD
Spread / Average Target
+47.51%
Consensus